Company Description
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally.
The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization.
In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications.
The company sells its products through a network of independent sales agents and direct sales representatives.
Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
| Country | United States |
| Founded | 1990 |
| IPO Date | Jun 2, 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 867 |
| CEO | Patrick Miles |
Contact Details
Address: 1950 Camino Vida Roble Carlsbad, California 92008 United States | |
| Phone | 760 431 9286 |
| Website | atecspine.com |
Stock Details
| Ticker Symbol | ATEC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001350653 |
| CUSIP Number | 02081G201 |
| ISIN Number | US02081G2012 |
| Employer ID | 20-2463898 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Patrick S. Miles | Executive Chairman, Chief Executive Officer and President |
| J. Todd Koning | Executive Vice President and Chief Financial Officer |
| Scott Lish | Chief Operating Officer |
| David P. Sponsel | Executive Vice President of Sales |
| Craig E. Hunsaker | Executive Vice President of People and Culture |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 8, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 5, 2025 | 144 | Filing |
| May 1, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Apr 29, 2025 | ARS | Filing |
| Apr 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 25, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 23, 2025 | SCHEDULE 13D/A | Filing |
| Apr 11, 2025 | SCHEDULE 13D/A | Filing |
| Apr 11, 2025 | PRE 14A | Other preliminary proxy statements |